Monthly Lectures | Third Wednesdays
The Henry Ford + MSU Distinguished Cancer Research Lecture Series aims to highlight exciting, cutting-edge cancer research, generate new ideas, and build new collaborations among Henry Ford Health, Michigan State University, and researchers at other cancer centers.
Faculty members, research staff, graduate/medical students, and health care professionals are invited to join this seminar series. Lectures will be on the third Wednesday of every month from noon to 1 p.m. (EST/EDT), alternating between the Henry Ford Health campus in Detroit and the Michigan State University campus in East Lansing. Lunch will be provided for in-person attendees.
No registration is required to participate in the Henry Ford + MSU Distinguished Cancer Research Lecture Series.
Locations
| Interdisciplinary Science Technology Building Room 1404 766 Service Rd East Lansing, MI | Henry Ford Hospital Room ER2096 2799 W Grand Blvd Detroit, MI |
Questions
For any questions, please contact Henry Ford + MSU Cancer Project Coordinator Jenna Anheuser, janheus3@hfhs.org.
Lectures
Lecture Topic
Topic will be provided at a later date.
About the Speaker
Eric A. Mellon, M.D., Ph.D., is a physician-scientist and professor research of Radiology at Michigan State University, with a clinical appointment at Henry Ford Health, where he serves as senior member and translational research vice-chair of radiation oncology. He is a board-certified radiation oncologist specializing in brain, spine, and skull base tumors. Mellon leads multidisciplinary, multi-institutional research programs integrating advanced imaging, radiotherapy, and molecular biomarkers to improve precision cancer care. He is actively involved in national clinical trials, mentoring trainees, and building collaborative translational research infrastructure across MSU and Henry Ford Health.
Additional lecture details will be provided at a later date.
Additional lecture details will be provided at a later date.
Additional lecture details will be provided at a later date.
Additional lecture details will be provided at a later date.
Additional lecture details will be provided at a later date.
2025 Speakers
- Marina Pasca di Magliano, Ph.D.
Presentation Topic: Oncogenic KRAS as a Regulator of the Local and Systemic Pancreatic Cancer Microenvironment - Sita Kugel, Ph.D.
Presentaiton Topic: Targeting Lineage Plasticity in Pancreatic Cancer - Weiping Zou, M.D., Ph.D.
Presentation Topic: Metabolic Impact on Cancer Immunity and Therapy
2026 Speakers
- Ralph Francescone, Ph.D. and Débora Vendramini Costa, Ph.D.
Normalization of Cancer Associated Fibroblast Pro-tumor Functions as a Therapeutic Opportunity in Pancreatic Cancer - William L. Hwang, M.D., Ph.D.
Presentation Topic: Cell-Intrinsic and -Extrinsic Neural Influences in Pancreatic Cancer - Clayton Yates, MS, Ph.D.
Reassessing Tumor Biology Through the Lens of African Ancestry - Li Zhou, Ph.D.
Targeting Unconventional T Cells in Cancer - Shawn Hervey-Jumper, M.D.
Breaking the Conversation: Therapeutics to Interrupt Tumor–Neuron Interactions
Learn More About Henry Ford + MSU Cancer Efforts